Pharmagreen Biotech Inc.

Drug Manufacturers - Specialty & Generic • Healthcare • Coquitlam, BC, United States • PHBI (PNK)

Pharmagreen Biotech Inc. operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. The company's primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. It also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for cultivation and live storage of any plant species services. It sells its products through online stores, such as Amazon and Shopify. Pharmagreen Biotech Inc. is headquartered in Coquitlam, Canada.

702 803 9404 2987 Blackbear Court, Coquitlam, BC V3E 3A2, Canada

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Check out Pharmagreen Biotech's stock price (PHBI) in real time - CNBC

CNBC • Jan 17

PHBI Pharmagreen Announces Another Milestone Completed Towards the Acquisition of Long Valley Farms LLC - GlobeNewswire

GlobeNewswire • May 24

Pharmagreen Biotech Inc. Announces the Formation of Independent Advisory Board - PR Newswire

PR Newswire • Sep 3

10 Penny Stocks That You Can Have for Less Than a Dime - InvestorPlace

InvestorPlace • Feb 11

Other Drug Manufacturers - Specialty & Generic Companies

View All →

Elanco Animal Health Inc.

Takeda Pharmaceutical Co. Ltd.

$47.02B market cap

Haleon PLC

$44.93B market cap

TEVA Pharmaceutical Industries Ltd.

$32.82B market cap

Frequently Asked Questions

Has Pharmagreen Biotech Inc. had layoffs?

No layoff events have been recorded for Pharmagreen Biotech Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

What industry is Pharmagreen Biotech Inc. in?

Pharmagreen Biotech Inc. operates in the Drug Manufacturers - Specialty & Generic industry, within the Healthcare sector.

Is Pharmagreen Biotech Inc. a publicly traded company?

Yes, Pharmagreen Biotech Inc. is publicly traded under the ticker symbol PHBI on the PNK. The company has a market capitalization of approximately $0.00 billion.

Where is Pharmagreen Biotech Inc. headquartered?

Pharmagreen Biotech Inc. is headquartered in Coquitlam, BC, United States at 2987 Blackbear Court, Coquitlam, BC V3E 3A2, Canada.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.